|
| |
| | | 67800 | | 11.06.2021 | | Sandoz Pharmaceuticals AG | | | | | | | 10.06.2026 | | | | | | 01.01.30. | | | | 01.01.30. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Fentalis 12 μg/h | Transdermales Pflaster | | N02AB03 | CI | | 02 | Fentalis 25 μg/h | Transdermales Pflaster | | N02AB03 | CI | | 03 | Fentalis 37.5 μg/h | Transdermales Pflaster | | N02AB03 | CI | | 04 | Fentalis 50 μg/h | Transdermales Pflaster | | N02AB03 | CI | | 05 | Fentalis 75 μg/h | Transdermales Pflaster | | N02AB03 | CI | | 06 | Fentalis 100 μg/h | Transdermales Pflaster | | N02AB03 | CI |
|
|
|
